Muscarinic M3 receptor antagonist

This page covers all Muscarinic M3 receptor antagonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting M3 muscarinic acetylcholine receptor.

Targets

M3 muscarinic acetylcholine receptor

Marketed (5)

• Toviaz (Fesoterodine) · Weill Medical College of Cornell University · Urology
  Fesoterodine is a muscarinic M3 receptor antagonist that relaxes bladder smooth muscle to reduce urinary incontinence and overactive bladder symptoms.
• Solifenacin for 24 weeks · National Taiwan University Hospital · Urology
  Solifenacin blocks muscarinic M3 receptors in the bladder smooth muscle, reducing involuntary contractions and increasing bladder capacity.
• Solifenacin succinate treatment · Barrie Urology Associates · Urology
  Solifenacin succinate is a muscarinic M3 receptor antagonist that reduces involuntary bladder muscle contractions.
• Solifenacin PO · Seattle Urology Research Center · Urology
  Solifenacin is a muscarinic M3 receptor antagonist that reduces bladder muscle contractions to treat overactive bladder.
• solifenacin succinate suspension · Astellas Pharma Inc · Urology
  Solifenacin is a muscarinic M3 receptor antagonist that reduces bladder muscle contractions to treat overactive bladder.

Phase 3 pipeline (2)

• Fesoterodine PR · Pfizer · Urology
  Fesoterodine is a muscarinic M3 receptor antagonist that relaxes bladder smooth muscle to reduce urinary incontinence and overactive bladder symptoms.
• Placebo to Tolterodine · Astellas Pharma Inc · Urology
  Tolterodine is a muscarinic M3 receptor antagonist that reduces bladder muscle contractions to treat overactive bladder symptoms.